


Searching News Database: Novo A/S
HSMN NewsFeed - 3 Jun 2014
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
HSMN NewsFeed - 27 May 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
HSMN NewsFeed - 22 May 2014
iRhythm Secures $17 Million in Funding Led by Novo A/S as Company Sees Record Growth for Its ZIO(R) Service
iRhythm Secures $17 Million in Funding Led by Novo A/S as Company Sees Record Growth for Its ZIO(R) Service
HSMN NewsFeed - 5 Jul 2013
U.S. FDA Approves Zubsolv(R) for the Maintenance Treatment of Opioid Dependence
U.S. FDA Approves Zubsolv(R) for the Maintenance Treatment of Opioid Dependence
HSMN NewsFeed - 21 May 2012
Apollo Endosurgery Names Former Covidien Chairman and CEO Richard J. Meelia to Board of Directors
Apollo Endosurgery Names Former Covidien Chairman and CEO Richard J. Meelia to Board of Directors
HSMN NewsFeed - 28 Apr 2011
Cianna Medical Closes $12 Million in Funding for SAVI Breast Cancer Treatment
Cianna Medical Closes $12 Million in Funding for SAVI Breast Cancer Treatment
HSMN NewsFeed - 5 Apr 2010
Altheos Completes $20 Million Series A Financing to Develop Next-Generation Glaucoma Treatment
Altheos Completes $20 Million Series A Financing to Develop Next-Generation Glaucoma Treatment
HSMN NewsFeed - 5 Nov 2007
Synosia Therapeutics Announces Appointment of Vice President of Clinical Research and Development
Synosia Therapeutics Announces Appointment of Vice President of Clinical Research and Development
HSMN NewsFeed - 13 Aug 2007
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration
HSMN NewsFeed - 30 Jul 2007
Amira Pharmaceuticals Announces Appointment of First Chief Executive Officer
Amira Pharmaceuticals Announces Appointment of First Chief Executive Officer
HSMN NewsFeed - 13 Jun 2007
Logical Therapeutics Inc. Raises US $30M Series B to Advance Drug Pipeline Targeting Inflammatory Diseases
Logical Therapeutics Inc. Raises US $30M Series B to Advance Drug Pipeline Targeting Inflammatory Diseases
HSMN NewsFeed - 5 Dec 2006
Indevus and Sanofi-Aventis' Spin-Out Company, Novexel, Announce Out-licensing of Aminocandin Anti-fungal
Indevus and Sanofi-Aventis' Spin-Out Company, Novexel, Announce Out-licensing of Aminocandin Anti-fungal
HSMN NewsFeed - 17 May 2006
Cabrellis Pharmaceuticals Corporation Announces Corporate Launch and Founding Management Team
Cabrellis Pharmaceuticals Corporation Announces Corporate Launch and Founding Management Team
Additional items found! 12
Members Archive contains
12 additional stories matching:
Novo A/S
(Password required)
Novo A/S
(Password required)
